Position history for IEQ CAPITAL, LLC's holdings in NEUROCRINE BIOSCIENCES INC
IEQ CAPITAL, LLC holds 745,113 shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $105.7M as of 2025-Q4. The position was increased (++7.6% shares). NBIX represents 0.3% of IEQ CAPITAL, LLC's portfolio.
Current Value
$105.7M
Current Shares
745,113
Total Value Change
+$36M
Total Shares Change
+239,027
Other major holders of NBIX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 745,113 |
+7.6% |
| $105.7M |
| 0.3% |
| $140.95 |
39 |
| 2025-Q3 | Increased | 692,601 | +20.9% | $97.2M | 0.3% | $140.27 | 43 |
| 2025-Q2 | Increased | 572,973 | +6.7% | $72M | 0.4% | $125.42 | 38 |
| 2025-Q1 | Decreased | 537,017 | -3.7% | $59.4M | 0.5% | $113.16 | 0 |
| 2024-Q4 | Increased | 557,904 | +8.9% | $76.2M | 0.7% | $137.06 | 46 |
| 2024-Q3 | Increased | 512,480 | +1.3% | $59M | 0.7% | $115.06 | 42 |
| 2024-Q2 | Decreased | 506,086 | -0.0% | $69.7M | 0.9% | $137.67 | 0 |